| Home > In process > Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models. > print |
| 001 | 285040 | ||
| 005 | 20260209101311.0 | ||
| 024 | 7 | _ | |a 10.1038/s41531-025-01239-x |2 doi |
| 024 | 7 | _ | |a pmid:41545406 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC12847943 |2 pmc |
| 037 | _ | _ | |a DZNE-2026-00164 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schmidt, M. Y. |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models. |
| 260 | _ | _ | |a [London] |c 2026 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1770628275_24272 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Aging is the most significant risk factor for Parkinson's disease (PD), yet its role remains underexplored. The International Network for Parkinson's Disease Modelling and Aging (PD-AGE), funded by the Michael J. Fox Foundation, was established to address these challenges. Through collaborative efforts, the PD-AGE mouse-model working group developed a roadmap to prioritize mouse models, reach consensus on experimental approaches, and standardize protocols to investigate the intersection of aging and PD. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 700 | 1 | _ | |a Cuervo, A. M. |b 1 |
| 700 | 1 | _ | |a Double, K. L. |b 2 |
| 700 | 1 | _ | |a Ehninger, D. |0 P:(DE-2719)2289209 |b 3 |u dzne |
| 700 | 1 | _ | |a Goldberg, M. S. |b 4 |
| 700 | 1 | _ | |a Harvey, K. |b 5 |
| 700 | 1 | _ | |a Hoeijmakers, J. H. J. |b 6 |
| 700 | 1 | _ | |a Luk, K. C. |b 7 |
| 700 | 1 | _ | |a Mastroberardino, P. G. |b 8 |
| 700 | 1 | _ | |a Moore, D. J. |b 9 |
| 700 | 1 | _ | |a Niedernhofer, L. J. |b 10 |
| 700 | 1 | _ | |a Trudeau, L É |b 11 |
| 700 | 1 | _ | |a Jurk, D. |b 12 |
| 700 | 1 | _ | |a Andersen, J. K. |b 13 |
| 700 | 1 | _ | |a Bellantuono, I. |b 14 |
| 773 | _ | _ | |a 10.1038/s41531-025-01239-x |g Vol. 12, no. 1, p. 28 |0 PERI:(DE-600)2819218-7 |n 1 |p 28 |t npj Parkinson's Disease |v 12 |y 2026 |x 2373-8057 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/285040/files/DZNE-2026-00164.pdf |y Restricted |
| 856 | 4 | _ | |u https://pub.dzne.de/record/285040/files/DZNE-2026-00164.pdf?subformat=pdfa |x pdfa |y Restricted |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2289209 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NPJ PARKINSONS DIS : 2022 |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-04-10T15:43:48Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-04-10T15:43:48Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2024-04-10T15:43:48Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-04-10T15:43:48Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-11 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-11 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b NPJ PARKINSONS DIS : 2022 |d 2024-12-11 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-11 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-11 |
| 920 | 1 | _ | |0 I:(DE-2719)1013005 |k AG Ehninger |l Translational Biogerontology |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a EDITORS |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a I:(DE-2719)1013005 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|